Bailard’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-877
| Closed | -$248K | – | 725 |
|
|
2021
Q3 | $248K | Buy |
+877
| New | +$287K | 0.01% | 606 |
|
|
2021
Q2 | – | Sell |
-1,611
| Closed | -$451K | – | 709 |
|
|
2021
Q1 | $451K | Hold |
1,611
| – | – | 0.02% | 417 |
|
|
2020
Q4 | $394K | Buy |
1,611
+12
| +0.8% | +$3.1K | 0.02% | 381 |
|
|
2020
Q3 | $454K | Sell |
1,599
-189
| -11% | -$52.7K | 0.02% | 300 |
|
|
2020
Q2 | $478K | Buy |
1,788
+27
| +2% | +$8.12K | 0.03% | 274 |
|
|
2020
Q1 | $557K | Buy |
1,761
+138
| +9% | +$41.9K | 0.04% | 217 |
|
|
2019
Q4 | $482K | Sell |
1,623
-1
| -0.1% | -$277 | 0.03% | 292 |
|
|
2019
Q3 | $378K | Buy |
1,624
+150
| +10% | +$34.9K | 0.02% | 347 |
|
|
2019
Q2 | $345K | Buy |
1,474
+55
| +4% | +$12.7K | 0.02% | 378 |
|
|
2019
Q1 | $335K | Sell |
1,419
-856
| -38% | -$270K | 0.02% | 393 |
|
|
2018
Q4 | $685K | Buy |
2,275
+85
| +4% | +$27.1K | 0.05% | 251 |
|
|
2018
Q3 | $774K | Sell |
2,190
-301
| -12% | -$104K | 0.05% | 243 |
|
|
2018
Q2 | $723K | Buy |
2,491
+460
| +23% | +$129K | 0.04% | 263 |
|
|
2018
Q1 | $556K | Buy |
2,031
+757
| +59% | +$235K | 0.04% | 300 |
|
|
2017
Q4 | $406K | Buy |
+1,274
| New | +$409K | 0.03% | 337 |
|
|
2016
Q4 | – | Sell |
-5,056
| Closed | -$1.58M | – | 306 |
|
|
2016
Q3 | $1.58M | Buy |
5,056
+2,723
| +117% | +$806K | 0.15% | 134 |
|
|
2016
Q2 | $564K | Buy |
+2,333
| New | +$615K | 0.07% | 189 |
|
|
2016
Q1 | – | Sell |
-2,200
| Closed | -$674K | – | 261 |
|
|
2015
Q4 | $674K | Buy |
+2,200
| New | +$632K | 0.3% | 111 |
|
Other funds holding BIIB
